Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Detection and pharmacokinetics of a cytomegalovirus (CMV) DNA plasmid in human plasma during a clinical trial of an intramuscular CMV vaccine in hematopoietic stem cell transplant recipients.

Transplant infectious disease : an official journal of the Transplantation Society·2014
Same author

Vaccination adherence in hematopoietic stem cell transplant patients: a pilot study on the impact of vaccination cards and reminder telephone calls.

Transplant infectious disease : an official journal of the Transplantation Society·2013
Same author

In vitro-in vivo correlation of voriconazole resistance due to G448S mutation (cyp51A gene) in Aspergillus fumigatus.

Diagnostic microbiology and infectious disease·2012
Same author

Significant interaction of tacrolimus with ritonavir during allogeneic hematopoietic SCT in an HIV-infected patient.

Bone marrow transplantation·2011
Same author

Clinical impact of the use of 16S rRNA sequencing method for the identification of "difficult-to-identify" bacteria in immunocompromised hosts.

Transplant infectious disease : an official journal of the Transplantation Society·2011
Same author

Weissella confusa: an unexpected cause of vancomycin-resistant gram-positive bacteremia in immunocompromised hosts.

Transplant infectious disease : an official journal of the Transplantation Society·2010

Related Experiment Video

Updated: Jul 17, 2026

Differentiating Functional Roles of Gene Expression from Immune and Non-immune Cells in Mouse Colitis by Bone Marrow Transplantation
14:43

Differentiating Functional Roles of Gene Expression from Immune and Non-immune Cells in Mouse Colitis by Bone Marrow Transplantation

Published on: October 1, 2012

Antimicrobial prophylaxis in bone marrow transplantation

F Momin1, P H Chandrasekar

  • 1Wayne State University, Detroit, Michigan, USA.

Annals of Internal Medicine
|August 1, 1995
PubMed
Summary

Antimicrobial prophylaxis in bone marrow transplantation can prevent common infections but does not always improve survival. Strategies require careful evaluation for toxicity and cost-effectiveness.

Area of Science:

  • Hematology
  • Infectious Diseases
  • Pharmacology

Background:

  • Bone marrow transplantation (BMT) recipients are highly susceptible to infections due to profound immunosuppression.
  • Prophylaxis with antimicrobial agents is a critical component of supportive care in BMT.

Purpose of the Study:

  • To review the efficacy of various antimicrobial prophylaxis strategies in bone marrow transplantation.
  • To evaluate the impact of prophylaxis on bacterial, viral, and fungal infections.

Main Methods:

  • Systematic review of English-language literature from 1975 to 1994.
  • MEDLINE search and review of bibliographies of selected articles.
  • Inclusion of studies on antimicrobial agents for infection prevention in BMT recipients and neutropenic cancer patients.

More Related Videos

Busulfan as a Myelosuppressive Agent for Generating Stable High-level Bone Marrow Chimerism in Mice
11:25

Busulfan as a Myelosuppressive Agent for Generating Stable High-level Bone Marrow Chimerism in Mice

Published on: April 1, 2015

Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis
08:00

Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis

Published on: May 26, 2021

Related Experiment Videos

Last Updated: Jul 17, 2026

Differentiating Functional Roles of Gene Expression from Immune and Non-immune Cells in Mouse Colitis by Bone Marrow Transplantation
14:43

Differentiating Functional Roles of Gene Expression from Immune and Non-immune Cells in Mouse Colitis by Bone Marrow Transplantation

Published on: October 1, 2012

Busulfan as a Myelosuppressive Agent for Generating Stable High-level Bone Marrow Chimerism in Mice
11:25

Busulfan as a Myelosuppressive Agent for Generating Stable High-level Bone Marrow Chimerism in Mice

Published on: April 1, 2015

Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis
08:00

Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis

Published on: May 26, 2021

Main Results:

  • Quinolones reduce Gram-negative infections but increase Gram-positive infections.
  • Ganciclovir and high-dose acyclovir show efficacy against cytomegalovirus (CMV) and herpes simplex virus (HSV), respectively, with associated concerns.
  • Fluconazole is effective against certain Candida species, while trimethoprim-sulfamethoxazole reduces Pneumocystis pneumonia and late bacterial infections.
  • No optimal prophylaxis exists for Aspergillus or post-engraftment fungal infections.

Conclusions:

  • Antimicrobial prophylaxis can prevent common early infections in BMT patients.
  • Survival benefit from prophylactic strategies is not consistently demonstrated.
  • Critical evaluation of toxicity and cost-effectiveness is essential for optimal antimicrobial prophylaxis in BMT.